• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDACTA INTERNATIONAL SA QUADRA H FEMORAL STEMS; QUADRA STEM STANDARD HAP 12/14 S.2

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDACTA INTERNATIONAL SA QUADRA H FEMORAL STEMS; QUADRA STEM STANDARD HAP 12/14 S.2 Back to Search Results
Model Number 01.12.022
Medical Device Problem Code Osseointegration Problem (3003)
Health Effect - Clinical Codes Inadequate Osseointegration (2646); Aseptic loosening (4883)
Date of Event 02/20/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Batch review performed on 20 february 2026.Stem: quadra-h 01.12.022 quadra stem standard hap 12/14 s.2 (k082792) lot 146367: (b)(4) items manufactured and released on 22-jan-2015.Expiration date: 31-dec-2019.No anomalies found related to the problem.To date, 50 items of the same lot have been sold with no similar reported event during the period of review.Clinical evaluation; 11 years after primary cementless tha, the stem is mobilized.From the pre-revision image supplied, it is evident that the stem did not get proper proximal fixation and ended up stress-shielding the femur, and achieving only distal fixation.A possible reason for this event at long term, when the stem was properly implanted and likely also properly dimensioned, is the change of patient bone shape and density over the years - a main factor in determining long-term revisions.No reason to suspect a faulty or deteriorated device in this case.R&d analysis from the image attached to the complaint and the informations reported it is visible one side of the expianted stem.The stem is covered by patient blood.On the body part no ha residuals are visible.Absorption of ha from the stem body can indicate that metabolic activity was taking place and that, presumably, adequate bone contact was achieved at the time of surgery.Some signs of minor damage and scratches are present on the neck of the explanted stem, which is likely due to the revision surgery and not relevant to the reported issue.It is not possible to add more hypotesis without a visual inspection of the expianted part.Based on the analysis completed and information available, it is not possible to identify a root cause of the reported complaint.Root cause:aseptic loosening is a possible literature-described adverse event after primary joint arthroplasties and causes are often unknown.There is no indication that any potential issue with the device may have caused or contributed to the event.No previous case has been addressed to a device design or manufacturing related root cause.
 
Event or Problem Description
The patient reported mid-thigh pain and diagnostic tests revealed spaces around the stem.At about 10 years and 9 months after the primary, a revision surgery was performed due to stem loosening.The surgeon removed the stem with minimal effort.No signs of infection were observed.A competitor cemented stem was implanted.The ceramic liner was removed and replaced with a polyethylene liner, according to the surgeon`s preference.The cup remained in situ.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QUADRA H FEMORAL STEMS
Common Device Name
QUADRA STEM STANDARD HAP 12/14 S.2
Manufacturer (Section D)
MEDACTA INTERNATIONAL SA
strada regina
castel san pietro 6874
SZ  6874
Manufacturer Contact
marco giannessi
strada regina
castel san pietro 6874
SZ   6874
MDR Report Key24588557
Report Number3005180920-2026-00213
Device Sequence Number13132926
Product Code JDI
UDI-Device Identifier07630030802034
UDI-Public07630030802034
Combination Product (Y/N)N
PMA/510(K) Number
K082792
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Device Explanted Year2026
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other
Type of Report Initial
Report Date (Section B) 03/13/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date12/31/2019
Device Model Number01.12.022
Device Lot Number146367
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/20/2026
Initial Report FDA Received Date03/13/2026
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured01/22/2015
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age65 YR
Patient SexFemale
Patient Weight82 KG
Patient RaceWhite
-
-